Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Myeloid 2Other hematologic neoplasm 1Classical hematology 1

Conditions

Leukemia, Myeloid, Acute 155Leukemia 96Precursor Cell Lymphoblastic Leukemia-Lymphoma 82Leukemia, Myelomonocytic, Acute 31Leukemia, Monocytic, Acute 31Leukemia, Erythroblastic, Acute 27Leukemia, Megakaryoblastic, Acute 25Congenital Abnormalities 23Burkitt Lymphoma 19Myelodysplastic Syndromes 17Lymphoma 17Leukemia, Biphenotypic, Acute 14Anemia, Refractory, with Excess of Blasts 11Myeloproliferative Disorders 10Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 8Leukemia, Eosinophilic, Acute 8Leukemia, Basophilic, Acute 8Leukemia, Promyelocytic, Acute 7Leukemia, Myelomonocytic, Chronic 7Recurrence 6Neoplasm, Residual 6Dendritic Cell Sarcoma, Interdigitating 5Hematologic Neoplasms 4Thrombocytopenia 3Neutropenia 3Neoplasms 3Myelodysplastic-Myeloproliferative Diseases 3Lymphoma, Non-Hodgkin 3Down Syndrome 3Thrombocythemia, Essential 2

Interventions

fludarabine phosphate 25Cyclophosphamide 24Peripheral Blood Stem Cell Transplantation 23Busulfan 17Tacrolimus 15Methotrexate 13Cyclosporine 13ruxolitinib 12Whole-Body Irradiation 12Mycophenolic Acid 12Antilymphocyte Serum 11Filgrastim 8Decitabine 7fludarabine 6Etoposide 611-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 6peginterferon alfa-2a 5Radiotherapy 5Methylprednisolone 5Cytarabine 5Carboplatin 5Prednisone 4Melphalan 4Biopsy 4Aspirin 4givinostat hydrochloride 3givinostat 3bomedemstat 3anagrelide 3Topotecan 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Thrombocythemia, Essential × Daunorubicin × Clear all
NCT03878199 2026-04-24

Testing the Effect of Taking Ruxolitinib and CPX-351 in Combination for the Treatment of Advanced Phase Myeloproliferative Neoplasms

Ohio State University Comprehensive Cancer Center

Phase 1/2 Terminated
12 enrolled 15 charts
Myeloid

Myeloproliferative Disorders, Polycythemia Vera, Thrombocythemia, Essential, Primary Myelofibrosis

NCT02084563 2016-11-08

Study of Molecular and Genetic Abnormalities in Patients With Myeloid Neoplasms

Hospital Israelita Albert Einstein

Phase 2 Completed
455 enrolled
Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Leukemia, Myelodysplastic Syndromes, Myeloproliferative Disorders, Polycythemia Vera, Thrombocythemia, Essential, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡